65 Results
Sort By:
Published on November 7, 2018
As 2019 looms before us, it is fair to say that significant—and perhaps surprising—advances will be made in the precision medicine and omics arenas, as there were in 2018. Can you say multi-marker, multi-drug CDxes? (More on the significant advances in the field in 2018 in our next issue). While…
Published on October 9, 2018
Scientists in Switzerland have used an enhanced CRISPR-Cas gene editing technology to correct the gene mutation that causes the metabolic disorder phenylketonuria (PKU), in mice, and restore blood levels of the amino acid phenylalanine, to normal. Reporting on the technology in Nature Medicine, the researchers say their results offer “compelling…
Published on September 27, 2018
Looking to spread the success it has achieved in fast genomic screening of severely ill newborns, Rady Children’s Hospital-San Diego is leveraging $2 million in funding from Medi-Call to launch Project Baby Bear, the first California State funded program to offer rapid whole genome sequencing (WGS) for critically-ill newborns. “We…
Published on March 8, 2017
Natera yesterday reported a 6.8% year-over-year decline in fourth-quarter revenues, though revenues for all of 2016 rose 14% over 2015, and the company’s number of tests processed jumped last year. The developer of molecular diagnostic tests reported Q4 revenues of $49.3 million, down from $52.9 million in the year-ago quarter.…
Published on April 2, 2015
Researchers report that the Harmony prenatal test by Ariosa Diagnostics undertaken between 10 to 14 weeks of pregnancy may be more effective in diagnosing Down syndrome and two other less common chromosomal abnormalities than standard noninvasive screening techniques. In the study (“Cell-free DNA Analysis for Noninvasive Examination of Trisomy”) published…